Skip to content

Clinical trials

Phase 3 Wet Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Wet Macular Degeneration Phase: Phase 3 Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20181
20196
20203
20213
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting3
Recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Outlook Therapeutics, Inc.5
4D Molecular Therapeutics2
Hoffmann-La Roche2
AbbVie1
Centre Hospitalier Intercommunal Creteil1
King's College Hospital NHS Trust1
OPKO Health, Inc.1
Opthea Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Wet Macular Degeneration19
Macular Degeneration16
Eye Diseases6
Retinal Degeneration5
Retinal Diseases5
Vision Disorders5
Choroidal Neovascularization4
Geographic Atrophy3
Retinal Vein Occlusion3
Blindness1

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.